Cytek Biosciences, Inc.CTKBNASDAQ

Revenue (LTM)

$201M

+0.5% YoY

Net Income (LTM)

$-67M

-1005.3% YoY

Free Cash Flow

$-9M

Revenue CAGR (5Y)

+16.8%

Marginsdeclining

FCFTurned negative

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	128	164↑28.2%	193↑17.7%	200↑3.9%	201↑0.5%
Gross Profit	79	101↑27.6%	109↑8.4%	111↑1.5%	104↓6.0%
Operating Income	9	-2↓119.7%	-28↓1443.5%	-21↑26.3%	-40↓96.8%
Net Income	3	3↓14.2%	-12↓571.6%	-6↑50.4%	-67↓1005.3%
EBITDA	9	9↑6.4%	-4↓146.4%	-10↓127.6%	-17↓73.3%
EPS Diluted	0.03	0.02↓43.6%	-0.09↓582.8%	-0.05↑48.7%	-0.52↓1028.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	365	297↓18.7%	167↓43.6%	99↓41.0%	91↓8.0%
Total Current Assets	432	454↑5.2%	392↓13.6%	396↑1.1%	392↓1.1%
Total Assets	463	519↑12.1%	494↓4.8%	500↑1.0%	462↓7.6%
Total Current Liabilities	33	49↑47.8%	56↑14.7%	68↑20.3%	78↑15.0%
Total Liabilities	58	94↑62.2%	101↑7.9%	104↑2.3%	120↑15.5%
Total Equity	405	425↑5.0%	393↓7.6%	396↑0.7%	342↓13.6%
Total Debt	0	18	14↓21.9%	17↑20.4%	33↑94.1%
Net Debt	-365	-279↑23.6%	-153↑45.0%	-82↑46.7%	-58↑29.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	5	-12↓364.2%	5↑143.2%	25↑380.6%	-5↓118.5%
Capital Expenditure	-4	-10↓126.1%	-5↑51.1%	-4↑27.0%	-4↓15.9%
Free Cash Flow	0	-22↓8407.9%	0↑102.1%	22↑4713.7%	-9↓140.1%
Stock-Based Comp	7	17↑152.0%	22↑32.9%	27↑21.8%	25↓8.4%
Net Change in Cash	198	-65↓132.8%	-132↓102.5%	-69↑47.8%	-8↑88.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance